Abstract: Video analytics systems and methods are described that typically comprise a video encoder operable to generate macroblock video analytics metadata (VAMD) from a video frame. Functional modules receive the VAMD and an encoded version of the video frame is configured to generate video analytics information related to the frame using the VAMD and the encoded video frame. The downstream decoder can use the VAMD to obtain a global motion vector related to the frame, detect and track motion of an object within the frame and monitor a line provided or found within the frame. Traversals of the line by a moving object can be detected and counted using information in the VAMD and the line may be part of a polygon that delineates an area to be monitored within the encoded frame. The VAMD can comprise macroblock level and video frame level information.

Abstract: The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein R1, R2, R3, and R4 are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk. In certain embodiments, also disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof, in combination with a vinca-alkaloid, or a pharmaceutically acceptable salt thereof.

Abstract: Methods, computer program products, and systems are presented. The methods include, for instance: locating, by one or more processor, at least one virtual machine within a virtual network, wherein gratuitous address resolution functionality of the at least one virtual machine is inactive; and providing, by the one or more processor, location information of the at least one virtual machine. In one embodiment, the locating comprises: receiving an IP address of the at least one virtual machine; and selecting a virtual machine hosting network device from a computing network node table, where the computing network node table comprises at least one network connection record of the silent virtual machine network device hosting a silent virtual machine having a known MAC address and an unknown IP address; and querying the silent virtual machine network device for a MAC address corresponding to the IP address of the at least one virtual machine.

Abstract: The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein X1, X2, X3, R2, R3, R4, R5, and Y are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk.

Abstract: Methods, computer program products, and systems are presented. The methods include, for instance: locating, by one or more processor, at least one virtual machine within a virtual network, wherein gratuitous address resolution functionality of the at least one virtual machine is inactive; and providing, by the one or more processor, location information of the at least one virtual machine. In one embodiment, the locating comprises: receiving an IP address of the at least one virtual machine; and selecting a virtual machine hosting network device from a computing network node table, where the computing network node table comprises at least one network connection record of the silent virtual machine network device hosting a silent virtual machine having a known MAC address and an unknown IP address; and querying the silent virtual machine network device for a MAC address corresponding to the IP address of the at least one virtual machine.

Abstract: The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein R1, R2, R3, and R4 are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk. In certain embodiments, also disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof, in combination with a vinca-alkaloid, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to an air-conditioning loop for heating, ventilation, and/or air-conditioning equipment in which a coolant circulates. The loop including a compressor comprising a coolant outlet connected to a delivery pipe and a coolant inlet connected to a suction pipe. The loop also including an internal heat exchanger which is capable of functioning at least as a condenser, and which is connected to the compressor via the delivery pipe. The loop also including an external unit which is connected to the compressor via the suction pipe and which includes at least one external heat exchanger capable of functioning at least as an evaporator, with the internal heat exchanger being connected to the external unit via a first intermediate duct comprising at least one pressure-release member. The loop includes a deicing pipe connected to the compressor and/or to the delivery pipe, as well as to the external unit.

Abstract: The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein R1, R2, R3, and R4 are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts or co-crystals thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk.

Abstract: A device for expanding a refrigerant fluid has a first inlet and a first outlet which are connected by a first refrigerant circulation duct. The first refrigerant circulation duct has an upstream part and a downstream part which parts are placed in communication by a first communication passage. The device also has a second inlet and a second outlet which are connected by a second refrigerant circulation duct. The device regulates an expansion of the refrigerant fluid and has a first needle valve housed inside the upstream part of the first refrigerant flow duct connected by a first connecting rod to a thermostatic sensor in communication with the second refrigerant flow duct that allows or prevents refrigerant fluid from circulating through the first communicating passage. The device also measures the pressure of the refrigerant fluid entering the evaporator (Pse) which pressure measurement is taken at the first outlet.

Abstract: An electrolyte for a lithium ion battery is provided, including a carrier, a lithium salt dissolved in the carrier, and an additive uniformly dispersed in the carrier, wherein the additive is an inorganic clay modified by an organic quaternary phosphonium salt. Also provided is a method for fabricating an electrolyte solution and a lithium ion battery.

Abstract: An air conditioning device is used in a motor vehicle. The air conditioning device includes air conditioning circuit, which includes a compressor (14), a condenser (11), and/or an internal exchanger, an electric expansion valve (12) which opening ratio is changed according to a control signal, and an evaporator (13), which are traversed in this order by a refrigerant fluid and a control unit (40) capable of controlling a control signal of the expansion valve so as to regulate a control variable relating to the superheating of the evaporator or to the sub-cooling of the condenser (11) according to a chosen regulation rule.

Abstract: The present disclosure directs to method, device, system for creating virtual credit card. The method may include: acquiring a subset of real-name information from a user interface of a terminal device; searching the real-name information stored in the first server with the subset of the real-name information; upon the real-name information is found in the first server, sending the real-name user information to a second server; finding whether the real-name information associates with a credit card account stored in the second server; after finding the credit card account is stored in the second server, creating, by the second server, a virtual credit card account; and storing the virtual credit card associated with the virtual credit card account in the data storage of the first server.

Abstract: A macroblock skip mode judgement method for an encoder applies to implementation of H.264 encoder hardware compressing a plurality of successive frames and comprises steps: undertaking IME (Integer Motion Estimation) for two frames appearing at neighboring time points to calculate MV (Motion Vector), and calculating PMV (Predicted Motion Vector) of the frame appearing the preceding time point; if MV equals PMV, modifying the cost function of MV to be a negative value; undertaking block encoding and compare the costs; if the cost of the Inter mode is smaller than the cost of the Intra mode, setting the mb (macroblock) skip flag to be 1; using Entropy to compress the mb skip flag, and omitting compressing the macroblock represented by the mb skip flag.

Abstract: The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein R1, R2, R3, and R4 are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts or co-crystals thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk.

Abstract: The present disclosure relates to compounds that are Syk inhibitors and to their use in the treatment of various disease states, including cancer and inflammatory conditions. In particular embodiments, the structure of the compounds is given by Formula I: wherein R1, R2, R3, and R4 are as described herein. The present disclosure further provides pharmaceutical compositions that include a compound of Formula I, or pharmaceutically acceptable salts thereof, and methods of using these compounds and compositions to treat conditions mediated by Syk. In certain embodiments, also disclosed are methods for treating a cancer in a subject (e.g., a human) in need thereof, comprising administering to the subject a therapeutically effective amount of a compound of formula I, or a pharmaceutically acceptable salt thereof, in combination with a vinca-alkaloid, or a pharmaceutically acceptable salt thereof.

Abstract: An electrochemical capacitor includes a positive electrode, a negative electrode disposed proximally to the positive electrode, and a non-aqueous electrolyte, wherein the positive electrode and the negative electrode are immersed in the non-aqueous electrolyte, and a case is presented in the energy storage system to accommodate the non-aqueous electrolyte, the positive electrode, and the negative electrode. The positive electrode has a porous matrix having a plurality of micrometer sized pores and nanostructured metal oxides, wherein the porous matrix is a 3-dimensional (3D) mesoporous metal or a 3D open-structured carbonaceous material, and the nanostructured metal oxides are coated inside the plurality of pores of the porous matrix.

Abstract: The present invention discloses an overlay switch (OSW) and a method used by the same. A received unicast packet needs to pass a waypoint chain including a number of waypoints. A network address of a first waypoint of the waypoint chain and an underlay network address of a second OSW connected to the first waypoint are obtained. In response to a determination that the second OSW is not the first OSW the unicast packet is encapsulated into a first underlay network packet according to a specification of an overlay network. A field of a destination header of the first underlay network packet includes the underlay network address of the second OSW. The first underlay network packet is sent to the second OSW.

Abstract: A command device (13) includes a sensor (15,16) for the measurement of a measured value VM of a characteristic C of a fluid FR,A and a comparison (14) of the measured value VM of the characteristic C of the fluid FR,A with at least two step-values VSmin, VSmax of the characteristic C. The command device (13) includes an upstream temperature sensor (20) to be positioned upstream the evaporator (12) according to the air flow direction (6) to measure an upstream temperature T2 of the air flow (3) and give an information (18) which is taken into account by the command device (13) in order to determine the step-values VSmin, VSmax of the characteristic C.

Abstract: An electrochemical capacitor includes a positive electrode, a negative electrode disposed proximally to the positive electrode, and a non-aqueous electrolyte, wherein the positive electrode and the negative electrode are immersed in the non-aqueous electrolyte, and a case is presented in the energy storage system to accommodate the non-aqueous electrolyte, the positive electrode, and the negative electrode. The positive electrode has a porous matrix having a plurality of micrometer sized pores and nanostructured metal oxides, wherein the porous matrix is a 3-dimensional (3D) mesoporous metal or a 3D open-structured carbonaceous material, and the nanostructured metal oxides are coated inside the plurality of pores of the porous matrix.